A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2. (Q38329978)

2 September 2017

title

A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2. (English)

1 reference

2 September 2017

Schaefer G

1

1 reference

2 September 2017

Akita RW

series ordinal

2

1 reference

2 September 2017

Sliwkowski MX

series ordinal

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

Journal of Biological Chemistry

2 September 2017

published in

1 reference

2 September 2017

volume

274

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

859-866

1 reference

Ligand-induced dimerization of growth factor receptors: variations on the theme

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Structure-function relationships for the EGF/TGF-alpha family of mitogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Binding of Neu Differentiation Factor with the Extracellular Domain of Her2 and Her3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Bivalence of EGF-like ligands drives the ErbB signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Mammalian cell transient expression of tissue factor for the production of antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Identification of heregulin, a specific activator of p185erbB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Rapid and efficient site-specific mutagenesis without phenotypic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Towards unraveling the complexity of T cell signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

The epidermal growth factor receptor as a multifunctional allosteric protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Signal transduction by allosteric receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

HIV-1 evolution and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

The type 1 (EGFR-related) family of growth factor receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Tyrosine kinase inhibition: an approach to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

Receptor blockade with monoclonal antibodies as anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

The epidermal growth factor receptor as a target for therapy in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.2.859

21 January 2018

Identifiers

DOI

10.1074/JBC.274.2.859

1 reference

2 September 2017

1 reference